Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/62248
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThanyawee Puthanakiten_US
dc.contributor.authorPenninah Oberdorferen_US
dc.contributor.authorSuchart Punjaiseeen_US
dc.contributor.authorPornphun Wannariten_US
dc.contributor.authorThira Sirisanthanaen_US
dc.contributor.authorVirat Sirisanthanaen_US
dc.date.accessioned2018-09-11T09:24:21Z-
dc.date.available2018-09-11T09:24:21Z-
dc.date.issued2005-10-01en_US
dc.identifier.issn10584838en_US
dc.identifier.other2-s2.0-25444482091en_US
dc.identifier.other10.1086/433177en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=25444482091&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/62248-
dc.description.abstractThe immune reconstitution syndrome caused by bacillus Calmette- Guérin (BCG) was found in 4 HIV-infected children who were immunized with BCG at birth. The localized, suppurative, BCG-related complications developed within 10 weeks after initiation of antiretroviral therapy. The incidence rate was 2.7 cases per 100 persons (95% confidence interval, 0.7-6.7). Patients responded well to treatment with isoniazid and rifampicin. © 2005 by the Infectious Diseases Society of America. All rights reserved.en_US
dc.subjectImmunology and Microbiologyen_US
dc.titleImmune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infectionen_US
dc.typeJournalen_US
article.title.sourcetitleClinical Infectious Diseasesen_US
article.volume41en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsThailand Ministry of Public Healthen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.